Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hyperhomocysteinemia relates to the subtype of antiphospholipid antibodies in non-SLE patients.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis - 1 Oct 2007

Chen Wei Hsi, Lin Hung Sheng, Kao Yi Fen, Lan Min Yu, Liu Jia Shou

Abstract excerpt

Abnormal increases of antiphospholipid antibody and plasma homocysteine levels are recently emerging as nonlipidic risk factors for cerebral atherogenesis and thrombosis. Both antiphospholipid antibody and homocysteine share many similar bioeffects in hemostasis, but their interaction is still inconsistent. In this study, we examined the relation between the plasma homocysteine level and lupus anticoagulant,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Anticardiolipin
Share to Antibodies, Antiphospholipid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiphospholipid Syndrome

Share to beta 2-Glycoprotein I

Share to Brain Ischemia

Share to Hyperhomocysteinemia

Share to Intracranial Arteriosclerosis

Share to Lupus Coagulation Inhibitor

Source

Identifiers

PMID: 17911191
DOI: 10.1177/1076029607303537

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hyperhomocysteinemia relates to the subtype of antiphospholipid antibodies in non-SLE patients.PMID 17911191Read ↗

Notable epigenetic role of hyperhomocysteinemia in atherogenesisSemantic proximity Read ↗

Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease.Semantic proximity Read ↗

Homocysteine: evidence for a causal relationship with cardiovascular disease.Semantic proximity Read ↗

Hyperhomocysteinemia and Endothelial Dysfunction in Multiple SclerosisSemantic proximity Read ↗

[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].Semantic proximity Read ↗

Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.Semantic proximity Read ↗

Homocysteine metabolism.Semantic proximity Read ↗

Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.Semantic proximity Read ↗

Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.Semantic proximity Read ↗

Factor V Leiden and prothrombin G20210A mutations and the risk of atherothrombotic events in systemic lupus erythematosus.Semantic proximity Read ↗

[Homocysteine metabolism and its role in pathology].Semantic proximity Read ↗

Mechanisms of homocysteine-induced atherothrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.